Detrunorm XL is a Modified Release Capsule (do not chew or swallow) and is indicated in adults for treatment of urinary incontinence symptoms and in patients with an overactive bladder. Detrunorm XL increases the ability of the bladder to hold more urine and prevents it from contracting. Detrunorm XL is taken only once daily.
Information about Detrunorm XL (Propiverine ER)
Detrunorm XL is an extended-release formulation of propiverine, a medication used to manage symptoms of overactive bladder (OAB). The extended-release formulation allows for sustained release of the medication over a longer period, providing continuous symptom control with a once-daily dosing schedule.
Product Highlights
- Used to manage symptoms including urinary urgency, frequency, and urge incontinence.
- Provides prolonged symptom relief through controlled, extended-release of the active ingredient
Key Ingredient
Key Benefits
- The extended-release formulation offers long-lasting symptom management with a single daily dose.
- Reduces urinary urgency, frequency, and urge incontinence effectively.
- Simplifies dosing with a once-daily schedule, improving adherence and convenience.
Direction of Use
- Take one extended-release tablet orally once daily, with or without food.
- Follow the prescribed dose and timing for optimal effectiveness.
- Take the tablet whole, and avoid chewing or crushing it.
Safety Concerns
- Typical side effects can include dry mouth, constipation, dizziness, and blurred vision. Rare but serious side effects may include urinary retention or allergic reactions.
- Regular follow-up with a healthcare provider is recommended to monitor effectiveness and manage any side effects.
- Propiverine can interact with other medications, including certain antihistamines and drugs that affect liver enzymes.
Avoid Detrunorm XL (Propiverine ER) If
- You are allergic to propiverine or any other components of the medication.
- Avoid use if you have conditions leading to impaired bladder emptying or urinary retention.
- Use with caution if you have severe gastrointestinal conditions such as gastric retention or severe constipation.
- Caution is advised if you have narrow-angle glaucoma, myasthenia gravis, or other conditions that could be exacerbated by anticholinergic effects.